1. Botanical Liposterols & 5-Alpha Reductase Research
- Wilt, T. et al. (Cochrane Database of Systematic Reviews): Saw palmetto extracts for treatment of benign prostatic hyperplasia. Analysis of multicentre randomized trials evaluating urodynamic outcomes and nocturia frequency.
- Debruyne, F. et al. (European Urology): Evaluation of a phytotherapeutic agent (Permixon) versus an alpha-blocker in symptomatic BPH over 12 months. Demonstrated non-inferior subjective symptom improvement without postural hypotension side-effects.
- Buck, A. C. (British Journal of Urology): Phytotherapy for the prostate: Evidence-based assessment of liposterols and beta-sitosterol.
2. Pumpkin Seed Sterols (Delta-7-Phytosterols)
- Vahlensieck, W. et al. (Urologia Internationalis): Effects of pumpkin seed in men with lower urinary tract symptoms: a randomized, double-blind, placebo-controlled trial. Demonstrated significant reduction in IPSS scores compared to placebo over 12 months.
- Nishimura, M. et al. (Journal of Traditional and Complementary Medicine): Pumpkin seed oil extracted from Cucurbita pepo improves urinary disorder in human overactive bladder.
3. Prostatic Zinc Homeostasis & Cellular Protection
- Costello, L. C. & Franklin, R. B. (Metabolomics & Oncology): The clinical significance of the decrease of zinc in prostate health. Human prostate tissue requires substantial intracellular zinc to maintain normal epithelial cell function and mitochondrial integrity.
- Gomez, Y. et al. (British Journal of Nutrition): Zinc status and dietary intake in mature men: Impact on cellular oxidative defense.
4. Circadian Sleep, Nocturia & Behavioral Medicine
- National Institute for Health and Care Excellence (NICE CG97): Lower urinary tract symptoms in men: management and clinical assessment. Official UK clinical guideline recommending evening fluid management and timed voiding as first-line non-invasive interventions.
- Breyer, B. N. et al. (Journal of Urology): Nocturia and sleep fragmentation in the elderly male: Association with metabolic risk and fall frequency.